Skip to main content

Table 1 Expression of VEGF and HIF-1α in each group

From: Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma

Groups

VEGF/GAPDH

HIF-1α/GAPDH

Control

0.515 ± 0.002 ##

0.555 ± 0.002 ##

MTD NVB

0.547 ± 0.003

0.754 ± 0.003

Endo+MTD NVB

0.639 ± 0.004 ##

0.868 ± 0.004 ##

Endo

0.346 ± 0.001

0.382 ± 0.002

MET NVB

0.181 ± 0.001

0.201 ± 0.001

Endo+MET NVB

0.078 ± 0.001**

0.041 ± 0.001**

  1. Data are presented as the mean ± SD. *P < 0.05, **P < 0.01 versus the control group; #P < 0.05, ##P < 0.01 versus the MET NVB+ Endo group
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us